Involvement of the sigma1 receptor in the motivational effects of ethanol in mice

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 4, 2003, Pages 869-876

  Maurice, Tangui ^a,b   Casalino, Magali ^a   Lacroix, Magali ^a   Romieu, Pascal ^a,b  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

Conditioned place preference; Conditioned taste aversion; Ethanol; Hyperlocomotion; Mouse; Reward; Sigma1 ( 1) receptor

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; ALCOHOL; ETHYLAMINE; LIGAND; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (DIMETHYLAMINO)ETHYLAMINE; OPIATE ANTAGONIST; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; DRUG TARGETING; HYPERACTIVITY; LOCOMOTION; MALE; MOTIVATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; TASTE AVERSION;

EID: 0037343993     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00002-9     Document Type: Article

References (50)

1. 1 receptor in the adult rat central nervous system. Neuroscience. 97:2000;155-170.
2. Boyce J.M., Risinger F.O. Enhancement of ethanol reward by dopamine D3 receptor blockade. Brain Res. 880:2000;202-206.
3. Carboni E., Silvagni A., Rolando M.T.P., Di Chiara G. Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J. Neurosci. 20(1-5):2000;RC102.
4. Carr G.D., Fibiger H.C., Philips A.G. Conditioned place preference as a measure of drug reward. Liebman J.M., Cooper S.J. Neuropharmacological basis of reward. 1989;264-319 Oxford Univ. Press, New York.
5. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 32:1993;281-307.
6. Cunningham C.L., Neihus D.R., Malott D.H., Prather L.K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology. 120:1992;28-41.
7. Cunningham C.L., Howard M.A., Gill S.J., Rubinstein M., Low M.J., Grandy D.K. Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol. Biochem. Behav. 67:2000;693-699.
8. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J. Psychopharmacol. 12:1998;54-67.
9. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
10. 1-binding site. Proc. Natl. Acad. Sci. USA. 93:1996;8072-8077.
11. Hayashi T., Su T.P. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc. Natl. Acad. Sci. USA. 98:2001;491-496.
12. 2+ concentration. J. Pharmacol. Exp. Ther. 293:2000;788-798.
13. Hunt T., Amit Z. Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci. Biobehav. 11:1987;107-130.
14. Kekuda R., Prasad P.D., Fei Y.J., Leibach F.H., Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 229:1996;553-558.
15. 1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using and antisense strategy. J. Chem. Neuroanat. 20:2000;375-387.
16. Koob G.F. Drug of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
17. Koob G.F. Drug addiction: the yin and yang of hedonic homeostasis. Neuron. 16:1996;893-896.
18. Koob G.F., Roberts A.J., Schulteis G., Parsons L.H., Heyser C.J., Hyytia P.et al. Neurocircuitry targets in ethanol reward and dependence. Alcohol. Clin. Exp. Res. 22:1998;3-9.
19. Kuhar M.J. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Ciba Found. Symp. 166:1992;81-89.
20. Matsumoto R.R., Bowen W.D., Tom M.A., Vo V.N., Truong D.D., De Costa B.R. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur. J. Pharmacol. 280:1995;301-310.
21. 1) receptor: pharmacological evidences and therapeutic opportunities. Jpn. J. Pharmacol. 81:1999;125-155.
22. 1) receptor function: behavioral consequences and therapeutic opportunities. Brain Res. Rev. 37:2001;116-132.
23. 1) receptor antagonists as a new promising strategy against cocaine addiction. Neurosci. Biobehav. Res. 26:2000;499-527.
24. McCracken K.A., Bowen W.D., Matsumoto R.R. Novel σ receptor ligands attenuate the locomotor stimulatory effects of cocaine. Eur. J. Pharmacol. 365:1999;35-38.
25. Menkel M., Terry M., Ponteorvo M., Katz J.L., Witkin J.M. Selective σ ligands block stimulant effects of cocaine. Eur. J. Pharmacol. 201:1991;251-252.
26. 1 receptor. J. Neurochem. 70:1998;2279-2285.
27. Phillips T.J., Shen E.H. Neurochemical bases of locomotion and ethanol stimulant effects. Int. Rev. Neurobiol. 39:1996;243-282.
28. Risinger F.O., Cunningham C.L. Genetic differences in ethanol-induced hyperglycemia and conditioned taste aversion. Life Sci. 50:1992;113-118.
29. Risinger F.O., Oakes R.A. Dose- and conditioning trial-dependent ethanol-induced conditioned place preference in Swiss-Webster mice. Pharmacol. Biochem. Behav. 55:1996;117-123.
30. Risinger F.O., Dickinson S.D., Cunningham C.L. Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference. Psychopharmacology. 107:1992;453-456.
31. Risinger F.O., Brown M.M., Oakes R.A., Love J.A. Effect of haloperidol or SCH-23390 on ethanol-induced conditioned taste aversion. Alcohol. 18:1999;139-145.
32. Risinger F.O., Freeman P.A., Greengard P., Fienberg A.A. Motivational effects of ethanol in DARPP-32 knock-out mice. J. Neurosci. 21:2001;340-348.
33. 1 receptor in the cocaine-induced conditioned place preference. NeuroReport. 11:2000;2885-2888.
34. 1 receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology. 26:2002;444-455.
35. Samson H.H., Hodge C.W., Tolliver G.A., Haraguchi M. Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens. Brain Res. Bull. 30:1993;133-141.
36. Samson H.H., Tolliver G.A., Pfeffer A.D., Sadeghi K., Haraguchi M. Relation of ethanol self administration to feeding and drinking in a nonrestricted access situation in rats initiated to self-administer ethanol using the sucrose-fading technique. Alcohol. 5:1993;375-385.
37. Schechter M.D., Calcagnetti D.J. Trends in place preference conditioning with a cross indexed bibliography; 1975-1991. Neurosci. Biobehav. Rev. 17:1993;21-41.
38. Seth P., Leibach F.H., Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem. Biophys. Res. Commun. 241:1997;535-540.
39. Seth P., Fie Y.J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J. Neurochem. 70:1998;922-931.
40. Sherman J.E., Jorenby D.E., Baker T.B. Classical conditioning with alcohol: acquired preferences and aversions, tolerance and urge/craving. Chaudron C.D., Wilkinson D.A. Theories on alcoholism. 1998;173-237 Addiction Research Foundation, Toronto.
41. Su T.P., Hayashi T. Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors. Trends Pharmacol. Sci. 22:2001;456-458.
42. Su T.P., Wu X.Z., Cone E.J., Shukla K., Gund T.M., Dodge A.L.et al. Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J. Pharmacol. Exp. Ther. 259:1991;543-548.
43. Tabakoff B., Hoffman P.L. Alcohol addiction: an enigma among us. Neuron. 16:1996;909-912.
44. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;613-672.
45. Ujike H., Kanzaki A., Okumura K., Akiyama K., Otsuka S. Sigma (σ) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci. 50:1992;PL129-PL134.
46. Ujike H., Kuroda S., Otsuka S. σ Receptor antagonists block the development of sensitization to cocaine. Eur. J. Pharmacol. 296:1996;123-128.
47. Weiss F., Lorang M.T., Bloom F.E., Koob G.F. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol. Exp. Ther. 267:1993;250-258.
48. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
49. Witkin J.M., Terry M., Menkel M., Hickey P., Pontecorvo M., Ferkany J.et al. Effects of the selective sigma receptor ligand 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. J. Pharmacol. Exp. Ther. 266:1993;473-482.
50. 1 receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand. Neurosci. Lett. 282:2000;169-172.